{
  "kind": "framework",
  "value": "dose-escalation-study",
  "collectionKey": "slides:framework:dose-escalation-study:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 1,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de075-a749-75ad-9c96-b2ef130e2f41",
      "docSlug": "810e8355c3b124b062a449d6b3848ba9",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 49 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The diagram illustrates a dose escalation study design with three cohorts leading to the RP2D.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Visual representation of clinical trial cohort progression",
      "slideHref": "/slides/019de075-a749-75ad-9c96-b2ef130e2f41/26",
      "deckHref": "/decks/019de075-a749-75ad-9c96-b2ef130e2f41",
      "deckAnchorHref": "/decks/019de075-a749-75ad-9c96-b2ef130e2f41#slide-26",
      "loopMatches": [
        {
          "to": 36,
          "from": 22,
          "name": "Pareto Focus",
          "slug": "50-pareto-focus",
          "bestFor": "Resource allocation, problem prioritization, efficiency improvements",
          "matchId": "24f91fa1-6eaa-45b1-9503-e96c3368cd2a",
          "evidence": "Presentation of market data and clinical development plan",
          "position": 1,
          "objective": "Focusing on key markets and opportunities",
          "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation",
          "confidence": 0.7,
          "description": "Show that 80% of results come from 20% of causes to drive prioritization"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 22,
          "beatId": "5ee20672-1046-46ce-ad33-eb1d695994e8",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "Discussion of market opportunity and clinical development plan",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}